MedPath

Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

Completed
Conditions
HIV Infections
Registration Number
NCT00001097
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to see if children and young adults with better immune systems before starting highly active antiretroviral therapy (HAART) do better than those who have weaker immune systems before starting HAART.

HIV infection weakens the immune system's ability to fight other infections and diseases. HAART is a type of anti-HIV therapy shown to improve the immune system of adults. However, not all patients show the same amount of improvement with HAART. Doctors believe that results may depend on how strong a patient's immune system is before starting HAART. Long-term effects of HAART in children and young adults have not yet been studied.

Detailed Description

Recent adult clinical trials involving combination HAART, including a protease inhibitor (PI), have demonstrated improvements in somatic immune system functioning. \[AS PER AMENDMENT 2/27/01: More recently, similar success has been demonstrated with a PI-sparing regimen, zidovudine, lamivudine, and efavirenz.\] Not all individuals, however, experience the same level of immune reconstitution, and oftentimes any improvement is short-lived. Adolescent patients may have a greater potential for immune restoration because of residual thymic tissue and therefore may experience greater long-term virus-free states as compared to adult patients. This study examines the duration of virologic efficacy HAART has on the adolescent HIV-positive population.

Patients begin study by initiating a HAART regimen of a minimum of 3 drugs, at least 1 of which must be a PI \[AS PER AMENDMENT 2/27/01: or efavirenz (EFV)\]. A variety of drug combinations are used; therefore, patients are grouped according to the classes of drugs in their respective regimen (e.g., 2 nucleoside reverse transcriptase inhibitors \[NRTIs\] plus 1 PI; 2 NRTIs plus 2 PIs; 1 or 2 NRTIs plus 1 PI plus 1 nonnucleoside reverse transcriptase inhibitor \[NNRTI\] \[AS PER AMENDMENT 2/27/01: ; and 2 NRTIs plus EFV\]). At the time of HAART initiation, patients undergo immunologic and virologic assessments in order to determine baseline values. Then, to determine the virologic success or failure of HAART, HIV-1 RNA measurements are taken and compared to initial baseline values. Virologic success equals undetectable HIV-1 RNA at Week 12 \[AS PER AMENDMENT 2/27/01: and confirmed at Week 16\] or a significant (greater than 1 log) decrease in HIV-1 RNA from baseline to Week 12 \[AS PER AMENDMENT 2/27/01: and confirmed undetectable HIV-1 RNA before the next scheduled visit (Week 24)\]. Patients are followed for a minimum of 3 years of maintained viral suppression or until they have demonstrated virologic failure. From these values, any correlation that may exist between HIV-1 RNA values and HAART can be deduced. Patients with virologic failure on the initial HAART regimen may be allowed to change to a second HAART regimen. \[AS PER AMENDMENT 2/27/01: Patients with virologic success on the second HAART regimen are followed for a minimum of 3 years.\] Patients with virologic failure on the second HAART regimen or who voluntarily discontinue HAART are followed using an abbreviated schedule for 3 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (46)

Univ of Illinois College of Medicine / Pediatrics

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Harbor - UCLA Med Ctr / UCLA School of Medicine

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Connecticut Children's Med Ctr

πŸ‡ΊπŸ‡Έ

Farmington, Connecticut, United States

Chicago Children's Memorial Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

SUNY Health Sciences Ctr at Syracuse / Pediatrics

πŸ‡ΊπŸ‡Έ

Syracuse, New York, United States

Children's Med Ctr of Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Children's Hosp of Boston

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Boston City Hosp / Pediatrics

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Duke Univ Med Ctr

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

Phoenix Childrens Hosp

πŸ‡ΊπŸ‡Έ

Phoenix, Arizona, United States

Children's Hosp of Denver

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

Univ of Alabama at Birmingham - Pediatric

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Children's Hosp of Michigan

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Howard Univ Hosp

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Los Angeles County - USC Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Univ of Florida Health Science Ctr / Pediatrics

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

San Juan City Hosp

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Saint Jude Children's Research Hosp of Memphis

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Univ of Puerto Rico / Univ Children's Hosp AIDS

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Ramon Ruiz Arnau Univ Hosp / Pediatrics

πŸ‡΅πŸ‡·

Bayamon, Puerto Rico

Children's Hosp of Philadelphia

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Texas Children's Hosp / Baylor Univ

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

Children's Hosp of the King's Daughters

πŸ‡ΊπŸ‡Έ

Norfolk, Virginia, United States

Children's Hospital & Medical Center / Seattle ACTU

πŸ‡ΊπŸ‡Έ

Seattle, Washington, United States

UCSD Med Ctr / Pediatrics / Clinical Sciences

πŸ‡ΊπŸ‡Έ

La Jolla, California, United States

Univ of South Alabama

πŸ‡ΊπŸ‡Έ

Mobile, Alabama, United States

Children's Hosp of Los Angeles/UCLA Med Ctr

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

North Broward Hosp District

πŸ‡ΊπŸ‡Έ

Fort Lauderdale, Florida, United States

Univ of Florida Gainesville

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Univ of Miami (Pediatric)

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Palm Beach County Health Dept

πŸ‡ΊπŸ‡Έ

Riviera Beach, Florida, United States

Emory Univ Hosp / Pediatrics

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Cook County Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Univ of Mississippi Med Ctr

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Univ of Chicago Children's Hosp

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Baystate Med Ctr of Springfield

πŸ‡ΊπŸ‡Έ

Springfield, Massachusetts, United States

Earl K Long Early Intervention Clinic

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Bronx Lebanon Hosp Ctr

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

North Shore Univ Hosp

πŸ‡ΊπŸ‡Έ

Great Neck, New York, United States

Montefiore Med Ctr Adolescent AIDS Program

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

SUNY - Brooklyn

πŸ‡ΊπŸ‡Έ

Brooklyn, New York, United States

Schneider Children's Hosp

πŸ‡ΊπŸ‡Έ

New Hyde Park, New York, United States

Bellevue Hosp / New York Univ Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Columbia Presbyterian Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Incarnation Children's Ctr / Columbia Presbyterian Med Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Harlem Hosp Ctr

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath